Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma
- PMID: 20033841
- DOI: 10.1007/s10620-009-1099-3
Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma
Abstract
Background: Secreted Frizzled-related protein 1 (sFRP1) is frequently silenced in many types of cancer, including hepatocellular carcinoma (HCC), leading to aberrant activation of Wnt signaling and thereby facilitating tumor development. In this study, we aimed to investigate whether restoration of sFRP1 affected HCC growth and metastasis.
Methods: We generated stable cell lines overexpressing sFRP1 in MHCC97-H cells, which naturally do not express detectable sFRP1 messenger RNA (mRNA) and have high metastatic properties. The effects of sFRP1 reexpression on tumor growth and metastasis were assessed in vitro and in vivo. It was also tested whether β-catenin signaling mediated the function of sFRP1 in tumor progression.
Results: Overexpression of sFRP1 substantially diminished the proliferation and invasion potentials of MHCC97-H cells. Furthermore, sFRP1 expression significantly inhibited MHCC97-H xenograft growth and metastasis in vivo, which was accompanied by decreased angiogenesis and increased tumor cell apoptosis. Moreover, sFRP1 overexpression caused less expression of β-catenin and its downstream effector genes cyclin D1 and matrix metalloproteinase (MMP)-2.
Conclusion: Together these findings demonstrate that sFRP1 reconstitution suppresses tumor growth, angiogenesis, and metastasis in MHCC97-H xenografts, which may be associated with inactivation of β-catenin signaling, thus providing a possible therapeutic strategy against HCC.
Similar articles
-
Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.Neoplasma. 2012;59(3):326-32. doi: 10.4149/neo_2012_042. Neoplasma. 2012. PMID: 22296502
-
Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.Oncogene. 2014 May 29;33(22):2826-35. doi: 10.1038/onc.2013.225. Epub 2013 Jun 17. Oncogene. 2014. PMID: 23770846
-
HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.Clin Sci (Lond). 2019 Jul 25;133(14):1645-1662. doi: 10.1042/CS20190225. Print 2019 Jul 31. Clin Sci (Lond). 2019. PMID: 31278131
-
Wnt signaling in liver cancer.Curr Drug Targets. 2008 Nov;9(11):1013-24. doi: 10.2174/138945008786786127. Curr Drug Targets. 2008. PMID: 18991612 Free PMC article. Review.
-
The mechanisms of renin-angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures.Biomed Pharmacother. 2021 Sep;141:111868. doi: 10.1016/j.biopha.2021.111868. Epub 2021 Jul 14. Biomed Pharmacother. 2021. PMID: 34328104 Review.
Cited by
-
DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.Tumour Biol. 2015 Jul;36(7):4973-8. doi: 10.1007/s13277-015-3147-2. Epub 2015 Feb 5. Tumour Biol. 2015. PMID: 25652468
-
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.J Med Chem. 2012 Sep 13;55(17):7378-91. doi: 10.1021/jm3002845. Epub 2012 Sep 4. J Med Chem. 2012. PMID: 22876979 Free PMC article.
-
Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma.Mol Med. 2014 Apr 8;20(1):164-78. doi: 10.2119/molmed.2013.00149. Mol Med. 2014. PMID: 24643460 Free PMC article.
-
Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation.Cancer Biol Ther. 2016 May 3;17(5):558-65. doi: 10.1080/15384047.2016.1177675. Cancer Biol Ther. 2016. PMID: 27124543 Free PMC article.
-
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma.Cancers (Basel). 2021 Nov 15;13(22):5717. doi: 10.3390/cancers13225717. Cancers (Basel). 2021. PMID: 34830873 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous